Development of the Renal Arterioles
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Lysophosphatidic Acid and Its Receptors: Pharmacology and Therapeutic Potential in Atherosclerosis and Vascular Disease
JPT-107404; No of Pages 13 Pharmacology & Therapeutics xxx (2019) xxx Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease Ying Zhou a, Peter J. Little a,b, Hang T. Ta a,c, Suowen Xu d, Danielle Kamato a,b,⁎ a School of Pharmacy, University of Queensland, Pharmacy Australia Centre of Excellence, Woolloongabba, QLD 4102, Australia b Department of Pharmacy, Xinhua College of Sun Yat-sen University, Tianhe District, Guangzhou 510520, China c Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, St Lucia, QLD 4072, Australia d Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA article info abstract Available online xxxx Lysophosphatidic acid (LPA) is a collective name for a set of bioactive lipid species. Via six widely distributed G protein-coupled receptors (GPCRs), LPA elicits a plethora of biological responses, contributing to inflammation, Keywords: thrombosis and atherosclerosis. There have recently been considerable advances in GPCR signaling especially Lysophosphatidic acid recognition of the extended role for GPCR transactivation of tyrosine and serine/threonine kinase growth factor G-protein coupled receptors receptors. This review covers LPA signaling pathways in the light of new information. The use of transgenic and Atherosclerosis gene knockout animals, gene manipulated cells, pharmacological LPA receptor agonists and antagonists have Gproteins fi β-arrestins provided many insights into the biological signi cance of LPA and individual LPA receptors in the progression Transactivation of atherosclerosis and vascular diseases. -
The Autotaxin–Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression During Oligodendrocyte Differentiation
The Journal of Neuroscience, August 12, 2015 • 35(32):11399–11414 • 11399 Cellular/Molecular The Autotaxin–Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation Natalie A. Wheeler,1 James A. Lister,2 and Babette Fuss1 Departments of 1Anatomy and Neurobiology and 2Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298 During development, oligodendrocytes (OLGs), the myelinating cells of the CNS, undergo a stepwise progression during which OLG progenitors, specified from neural stem/progenitor cells, differentiate into fully mature myelinating OLGs. This progression along the OLG lineage is characterized by well synchronized changes in morphology and gene expression patterns. The latter have been found to be particularly critical during the early stages of the lineage, and they have been well described to be regulated by epigenetic mechanisms, especially by the activity of the histone deacetylases HDAC1 and HDAC2. The data presented here identify the extracellular factor autotaxin (ATX) as a novel upstream signal modulating HDAC1/2 activity and gene expression in cells of the OLG lineage. Using the zebrafish as an in vivo model system as well as rodent primary OLG cultures, this functional property of ATX was found to be mediated by its lysophospholipase D (lysoPLD) activity, which has been well characterized to generate the lipid signaling molecule lysophosphatidic acid (LPA). More specifically, the lysoPLD activity of ATX was found to modulate HDAC1/2 regulated gene expression during a time window coinciding with the transition from OLG progenitor to early differentiating OLG. In contrast, HDAC1/2 regulated gene expression during the transition from neural stem/progenitor to OLG progenitor appeared unaffected by ATX and its lysoPLD activity. -
Crystal Structure of the Primary Pirna Biogenesis Factor Zucchini Reveals Similarity to the Bacterial PLD Endonuclease Nuc
Downloaded from rnajournal.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press LETTER TO THE EDITOR Crystal structure of the primary piRNA biogenesis factor Zucchini reveals similarity to the bacterial PLD endonuclease Nuc FRANKA VOIGT,1 MICHAEL REUTER,2,3 ANISA KASARUHO,2,3 EIKE C. SCHULZ,1 RAMESH S. PILLAI,2,3,4 and ORSOLYA BARABAS1,4 1European Molecular Biology Laboratory, 69117 Heidelberg, Germany 2European Molecular Biology Laboratory, 38042 Grenoble, France 3CNRS-UJF-EMBL International Unit (UMI 3265) for Virus Host Cell Interactions (UVHCI), 38042 Grenoble, France ABSTRACT Piwi-interacting RNAs (piRNAs) are a gonad-specific class of small RNAs that associate with the Piwi clade of Argonaute proteins and play a key role in transposon silencing in animals. Since biogenesis of piRNAs is independent of the double- stranded RNA-processing enzyme Dicer, an alternative nuclease that can process single-stranded RNA transcripts has been long sought. A Phospholipase D-like protein, Zucchini, that is essential for piRNA processing has been proposed to be a nuclease acting in piRNA biogenesis. Here we describe the crystal structure of Zucchini from Drosophila melanogaster and show that it is very similar to the bacterial endonuclease, Nuc. The structure also reveals that homodimerization induces major conforma- tional changes assembling the active site. The active site is situated on the dimer interface at the bottom of a narrow groove that can likely accommodate single-stranded nucleic acid substrates. Furthermore, biophysical analysis identifies protein segments essential for dimerization and provides insights into regulation of Zucchini’s activity. Keywords: Zucchini; piRNA; Piwi; nuclease; phospholipase; PLD6; MitoPLD INTRODUCTION stranded (ss) RNAs (Brennecke et al. -
Antibody Response Cell Antigen Receptor Signaling And
Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response This information is current as Jiancheng Hu, Shannon K. Oda, Kristin Shotts, Erin E. of September 24, 2021. Donovan, Pamela Strauch, Lindsey M. Pujanauski, Francisco Victorino, Amin Al-Shami, Yuko Fujiwara, Gabor Tigyi, Tamas Oravecz, Roberta Pelanda and Raul M. Torres J Immunol 2014; 193:85-95; Prepublished online 2 June 2014; Downloaded from doi: 10.4049/jimmunol.1300429 http://www.jimmunol.org/content/193/1/85 Supplementary http://www.jimmunol.org/content/suppl/2014/05/31/jimmunol.130042 http://www.jimmunol.org/ Material 9.DCSupplemental References This article cites 63 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/193/1/85.full#ref-list-1 Why The JI? Submit online. by guest on September 24, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response Jiancheng Hu,*,1,2 Shannon K. -
Regulatory Micrornas in Brown, Brite and White Adipose Tissue
cells Review Regulatory microRNAs in Brown, Brite and White Adipose Tissue Seley Gharanei 1,2, Kiran Shabir 3 , James E. Brown 3,4, Martin O. Weickert 1,2,5 , 1,2 1,2,3, 1,2,3, , Thomas M. Barber , Ioannis Kyrou y and Harpal S. Randeva * y 1 Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK; [email protected] (S.G.); [email protected] (M.O.W.); [email protected] (T.M.B.); [email protected] (I.K.) 2 Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK 3 Aston Medical Research Institute, Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK; [email protected] (K.S.); [email protected] (J.E.B.) 4 School of Biosciences, College of Health and Life Sciences, Aston University, Birmingham B4 7ET, UK 5 Centre of Applied Biological & Exercise Sciences, Faculty of Health & Life Sciences, Coventry University, Coventry CV1 5FB, UK * Correspondence: [email protected] Joint senior authors; contributed equally to the manuscript. y Received: 30 September 2020; Accepted: 13 November 2020; Published: 16 November 2020 Abstract: MicroRNAs (miRNAs) constitute a class of short noncoding RNAs which regulate gene expression by targeting messenger RNA, inducing translational repression and messenger RNA degradation. This regulation of gene expression by miRNAs in adipose tissue (AT) can impact on the regulation of metabolism and energy homeostasis, particularly considering the different types of adipocytes which exist in mammals, i.e., white adipocytes (white AT; WAT), brown adipocytes (brown AT; BAT), and inducible brown adipocytes in WAT (beige or brite or brown-in-white adipocytes). -
Survival-Associated Metabolic Genes in Colon and Rectal Cancers
Survival-associated Metabolic Genes in Colon and Rectal Cancers Yanfen Cui ( [email protected] ) Tianjin Cancer Institute: Tianjin Tumor Hospital https://orcid.org/0000-0001-7760-7503 Baoai Han tianjin tumor hospital He Zhang tianjin tumor hospital Zhiyong Wang tianjin tumor hospital Hui Liu tianjin tumor hospital Fei Zhang tianjin tumor hospital Ruifang Niu tianjin tumor hospital Research Keywords: colon cancer, rectal cancer, prognosis, metabolism Posted Date: December 4th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-117478/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/42 Abstract Background Uncontrolled proliferation is the most prominent biological feature of tumors. To rapidly proliferate and maximize the use of available nutrients, tumor cells regulate their metabolic behavior and the expression of metabolism-related genes (MRGs). In this study, we aimed to construct prognosis models for colon and rectal cancers, using MRGs to indicate the prognoses of patients. Methods We rst acquired the gene expression proles of colon and rectal cancers from the TCGA and GEO database, and utilized univariate Cox analysis, lasso regression, and multivariable cox analysis to identify MRGs for risk models. Then GSEA and KEGG functional enrichment analysis were utilized to identify the metabolism pathway of MRGs in the risk models and analyzed these genes comprehensively using GSCALite. Results Eight genes (CPT1C, PLCB2, PLA2G2D, GAMT, ENPP2, PIP4K2B, GPX3, and GSR) in the colon cancer risk model and six genes (TDO2, PKLR, GAMT, EARS2, ACO1, and WAS) in the rectal cancer risk model were identied successfully. Multivariate Cox analysis indicated that the models predicted overall survival accurately and independently for patients with colon or rectal cancer. -
Phosphodiesterase (PDE)
Phosphodiesterase (PDE) Phosphodiesterase (PDE) is any enzyme that breaks a phosphodiester bond. Usually, people speaking of phosphodiesterase are referring to cyclic nucleotide phosphodiesterases, which have great clinical significance and are described below. However, there are many other families of phosphodiesterases, including phospholipases C and D, autotaxin, sphingomyelin phosphodiesterase, DNases, RNases, and restriction endonucleases, as well as numerous less-well-characterized small-molecule phosphodiesterases. The cyclic nucleotide phosphodiesterases comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP. They regulate the localization, duration, and amplitude of cyclic nucleotide signaling within subcellular domains. PDEs are therefore important regulators ofsignal transduction mediated by these second messenger molecules. www.MedChemExpress.com 1 Phosphodiesterase (PDE) Inhibitors, Activators & Modulators (+)-Medioresinol Di-O-β-D-glucopyranoside (R)-(-)-Rolipram Cat. No.: HY-N8209 ((R)-Rolipram; (-)-Rolipram) Cat. No.: HY-16900A (+)-Medioresinol Di-O-β-D-glucopyranoside is a (R)-(-)-Rolipram is the R-enantiomer of Rolipram. lignan glucoside with strong inhibitory activity Rolipram is a selective inhibitor of of 3', 5'-cyclic monophosphate (cyclic AMP) phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM phosphodiesterase. and 240 nM for PDE4A, PDE4B, and PDE4D, respectively. Purity: >98% Purity: 99.91% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 1 mg, 5 mg Size: 10 mM × 1 mL, 10 mg, 50 mg (R)-DNMDP (S)-(+)-Rolipram Cat. No.: HY-122751 ((+)-Rolipram; (S)-Rolipram) Cat. No.: HY-B0392 (R)-DNMDP is a potent and selective cancer cell (S)-(+)-Rolipram ((+)-Rolipram) is a cyclic cytotoxic agent. (R)-DNMDP, the R-form of DNMDP, AMP(cAMP)-specific phosphodiesterase (PDE) binds PDE3A directly. -
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
International Journal of Molecular Sciences Review Macrophages/Microglia in the Glioblastoma Tumor Microenvironment Jun Ma, Clark C. Chen * and Ming Li * Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA; [email protected] * Correspondence: [email protected] (C.C.C.); [email protected] (M.L.) Abstract: The complex interaction between glioblastoma and its microenvironment has been rec- ognized for decades. Among various immune profiles, the major population is tumor-associated macrophage, with microglia as its localized homolog. The present definition of such myeloid cells is based on a series of cell markers. These good sentinel cells experience significant changes, facilitat- ing glioblastoma development and protecting it from therapeutic treatments. Huge, complicated mechanisms are involved during the overall processes. A lot of effort has been dedicated to crack the mysterious codes in macrophage/microglia recruiting, activating, reprogramming, and functioning. We have made our path. With more and more key factors identified, a lot of new therapeutic methods could be explored to break the ominous loop, to enhance tumor sensitivity to treatments, and to improve the prognosis of glioblastoma patients. However, it might be a synergistic system rather than a series of clear, stepwise events. There are still significant challenges before the light of truth can shine onto the field. Here, we summarize recent advances in this field, reviewing the path we have been on and where we are now. Keywords: glioblastoma; tumor microenvironment; glioblastoma-associated macrophages/microglia; macrophage; microglia Citation: Ma, J.; Chen, C.C.; Li, M. Macrophages/Microglia in the Glioblastoma Tumor Int. J. Mol. Sci. Microenvironment. 1. Glioblastoma Associated Macrophages/Microglia 2021, 22, 5775. -
Identification of Genes That Affect Acetylcholine
IDENTIFICATION OF GENES THAT AFFECT ACETYLCHOLINE SIGNALING AT THE C. ELEGANS NEUROMUSCULAR JUNCTION by Shrey Patel A thesis submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the degree of Honors Bachelor of Arts in Biological Sciences with Distinction Spring 2018 © 2018 Shrey Patel All Rights Reserved IDENTIFICATION OF GENES THAT AFFECT ACETYLCHOLINE SIGNALING AT THE C. ELEGANS NEUROMUSCULAR JUNCTION by Shrey Patel Approved: __________________________________________________________ Jessica Tanis, Ph.D. Professor in charge of thesis on behalf of the Advisory Committee Approved: __________________________________________________________ Donna Woulfe, Ph.D. Committee member from the Department of Biological Sciences Approved: __________________________________________________________ Carlton Cooper, Ph.D. Committee member from the Board of Senior Thesis Readers Approved: __________________________________________________________ Paul Laux, Ph.D. Director, University Honors Program ACKNOWLEDGMENTS I would like to first thank Dr. Jessica Tanis for giving me the opportunity to conduct research towards a senior thesis. Her guidance, support, and encouragement throughout the process have been invaluable. Her mentorship has changed my views on research, helped me grow professionally and personally, and opened doors previously unimagined. I could not be more grateful. I would not be where I am without the assistance of the Tanis Lab team: Kirsten Kervin, Elaine Miller, Andy Lam, Michael Clupper, Amanda Addiego, Denis Touroutine, and Alyssa Reed. Thank you for help with laboratory techniques, input on my presentations, and for being great team members. I would like to specially thank Amanda, Kirsten, and Elaine for their contributions to this project, which has made significant progress in just one year. I could not have wished to be in another lab, for the enriching, collaborative, and friendly environment cannot be replicated. -
Microrna Co-Expression Networks Exhibit Increased Complexity in Pancreatic Ductal Compared to Vater’S Papilla Adenocarcinoma
www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 62), pp: 105320-105339 Research Paper MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater’s papilla adenocarcinoma Tommaso Mazza1, Massimiliano Copetti2, Daniele Capocefalo1,8, Caterina Fusilli1, Tommaso Biagini1, Massimo Carella3, Antonio De Bonis4, Nicola Mastrodonato4, Ada Piepoli5, Valerio Pazienza5, Evaristo Maiello6, Fabio Francesco di Mola7, Pierluigi di Sebastiano7, Angelo Andriulli5 and Francesca Tavano5 1Unit of Bioinformatics, Research Hospital, San Giovanni Rotondo 71013, Italy 2Unit of Biostatistics, Research Hospital, San Giovanni Rotondo 71013, Italy 3Medical Genetics Unit, Research Hospital, San Giovanni Rotondo 71013, Italy 4Department of Surgery, Research Hospital, San Giovanni Rotondo 71013, Italy 5Division of Gastroenterology and Research Laboratory, San Giovanni Rotondo 71013, Italy 6Department of Oncology IRCCS “Casa Sollievo della Sofferenza”, Research Hospital, San Giovanni Rotondo 71013, Italy 7Division of Surgical Oncology “SS Annunziata” Hospital, Chieti 66100, Italy 8Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome 00161, Italy Correspondence to: Francesca Tavano, email: [email protected] Keywords: microRNA; pancrearic ductal adenocarcinoma; ampullary carcinoma Received: December 06, 2016 Accepted: July 11, 2017 Published: October 31, 2017 Copyright: Mazza et al. This is an open-access article distributed under the terms of the Creative Commons Attribution -
Phosphoproteomics Identify Arachidonic-Acid-Regulated Signal Transduction Pathways Modulating Macrophage Functions with Implications for Ovarian Cancer
Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer Raimund Dietze1¶, Mohamad K. Hammoud1¶, María Gómez-Serrano1, Annika Unger1, Tim Bieringer1§, Florian Finkernagel1, Anna M. Sokol2,3, Andrea Nist4, Thorsten Stiewe4, Silke Reinartz1, Viviane Ponath5, Christian Preußer5, Elke Pogge von Strandmann5, Sabine Müller- Brüsselbach1, Johannes Graumann2,3 and Rolf Müller1* 1Tranlational OncologY Group, Center for Tumor BiologY and Immunology, Philipps University, Marburg, GermanY 2Biomolecular Mass Spectrometry, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, GermanY 3The German Centre for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Max Planck Institute for Heart and Lung Research, Bad Nauheim, GermanY 4Genomics Core Facility, Philipps UniversitY, Marburg, GermanY 5Institute for Tumor Immunology, Philipps University, Marburg, GermanY §Present address: Hochschule Landshut, 84036 Landshut, GermanY ¶Equal contribution *Corresponding author: Rolf Müller, Center for Tumor Biology and Immunology (ZTI), Philipps University, Hans-Meerwein-Strasse 3, 35043 Marburg, GermanY. Email: [email protected]. Phone: +49 6421 2866236. Running title: Signaling pathways of arachidonic acid in macrophages 1 Abstract Arachidonic acid (AA) is a polYunsaturated fatty acid present at high concentrations in the ovarian cancer (OC) microenvironment and associated with a poor clinical outcome. In the present studY, we have unraveled a potential link between AA and macrophage functions. Methods: AA-triggered signal transduction was studied in primary monocyte-derived macrophages (MDMs) by phosphoproteomics, transcriptional profiling, measurement of intracellular Ca2+ accumulation and reactive oxygen species production in conjunction with bioinformatic analyses. Functional effects were investigated by actin filament staining, quantification of macropinocytosis and analysis of extracellular vesicle release. -
Lysophosphatidic Acids, Cyclic Phosphatidic Acids and Autotaxin As Promissing Targets in Therapies of Cancer and Other Diseases
Vol. 55 No. 2/2008, 227–240 on-line at: www.actabp.pl Review Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promissing targets in therapies of cancer and other diseases Edyta Gendaszewska-Darmach Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Technical University of Łódź, Łódź, Poland Received: 17 March, 2008; revised: 20 May, 2008; accepted: 30 May, 2008 available on-line: 14 June, 2008 Lysophospholipids have long been recognized as membrane phospholipid metabolites, but only recently lysophosphatidic acids (LPA) have been demonstrated to act on specific G protein-cou- pled receptors. The widespread expression of LPA receptors and coupling to several classes of G proteins allow LPA-dependent regulation of numerous processes, such as vascular development, neurogenesis, wound healing, immunity, and cancerogenesis. Lysophosphatidic acids have been found to induce many of the hallmarks of cancer including cellular processes such as prolifera- tion, survival, migration, invasion, and neovascularization. Furthermore, autotaxin (ATX), the main enzyme converting lysophosphatidylcholine into LPA was identified as a tumor cell auto- crine motility factor. On the other hand, cyclic phosphatidic acids (naturally occurring analogs of LPA generated by ATX) have anti-proliferative activity and inhibit tumor cell invasion and metastasis. Research achievements of the past decade suggest implementation of preclinical and clinical evaluation of LPA and its analogs, LPA receptors, as well as autotaxin as potential thera- peutic targets. Keywords: autotaxin/NPP2, lysophosphatidic acid, cyclic phosphatidic acid, G protein-coupled receptors INTRODUCTION small amounts of LPA associated with membrane biosynthesis, some cellular sources (such as activat- Lysophosphatidic acids (LPA; 1-acyl-2-hy- ed platelets) can produce significant amounts of ex- droxy-sn-glycero-3-phosphates) (Fig.